| 1. | Merck Frosst Canada - Overview |
| | This line of research led to the development of the oral asthma medication, SINGULAIR® (montelukast sodium), a leukotriene D4 receptor antagonist that has now been approved in Canada for children as young as 6 years of age.... |
| |
| 2. | Merck Frosst Canada - Partners |
| | A child is able to breathe more easily when running and playing because of our asthma medication.... |
| |
| 3. | Merck Frosst Canada - Partners |
| | This line of research has led to the development of SINGULAIR® (montelukast sodium), an oral asthma medication that adults and children as young as age two can take daily to control their asthma symptoms.... |
| |
| 4. | Merck Frosst Canada - Our History |
| | Scientists at the Merck Frosst Centre for Therapeutic Research have been investigating leukotrienes since 1979. This line of research led to the development of SINGULAIR® (montelukast sodium) an oral asthma medication that adults and children as young as two can take daily to control their asthma symptoms.... |
| |
| 5. | Asthma - Adults |
| | There are two main groups of asthma medications :... |
| |
| 6. | Asthma - Adults |
| | It is important to take your asthma medication correctly.... |
| |
| 7. | Asthma - Parents |
| | Ask your pharmacist or asthma educator to look at the way your child is using his or her medication to make sure they are getting the most from their asthma medication.... |
| |
| 8. | Asthma - Kids |
| | Asthma - KidsThere are two main groups of asthma medications :Daily medicines. |
| |
